Mon.Jan 15, 2024

article thumbnail

9 Hot Takes from JPM24

MedCity News

I didn’t make it to this year’s J.P. Morgan Healthcare Conference in San Francisco, so I reached out to leaders from across the industry to hear how it went and learn about their takeaways from the event. This is a list of the nine most interesting responses that I received.

article thumbnail

AI could revolutionise pharma compound synthesis

pharmaphorum

Researchers at the University of Cambridge and Pfizer have developed an AI-powered approach to make it easier to design and make pharma molecules

Pharma 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

If Dexcom’s CEO Had a Magic Wand …

MedCity News

Kevin Sayer would love to bring his company’s Dexcom G7 continuous glucose monitor to more people and more quickly. But despite being CEO of a successful device company, he feels frustrated from time to time about how and what the U.S. health system will pay for.

122
122
article thumbnail

Keytruda breaks new ground in cervical cancer

pharmaphorum

MSD’s Keytruda has been cleared by the FDA as the first PD-1 inhibitor for newly diagnosed cervical cancer patients with less severe disease

FDA 115
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Genetic Medicines Biotech Dyne Pulls In $345M for Clinical Tests of Muscle Drugs

MedCity News

Dyne Therapeutics recently reported encouraging Phase 1/2 clinical data in myotonic dystrophy type 1 and Duchenne muscular dystrophy. At the J.P. Morgan Healthcare Conference, CEO Joshua Brumm said Dyne’s existing cash combined with the new capital is expected to last through 2025—well beyond the next key milestones for both therapeutic candidates.

Medicine 120
article thumbnail

As Novartis backs off, Amgen said to be after Cytokinetics

pharmaphorum

Speculation about a takeover play for Cytokinetics isn’t going away, with Amgen the latest company to be linked to the company and its highly-anticipated cardiovascular drug aficamten.

109
109

More Trending

article thumbnail

Keytruda Granted Latest FDA Approval in Cervical Cancer

Pharmaceutical Commerce

FDA approves Keytruda (pembrolizumab) combined with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer, which is the 39th overall approved indication for the drug in the United States.

FDA 107
article thumbnail

MHRA approves ‘safer’ medicine alternative for rare disease

European Pharmaceutical Review

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Agamree ® (vamorolone), as a safer alternative to corticosteroids, for Duchenne muscular dystrophy (DMD). “In addition to its anti-inflammatory efficacy, both the EMA and the MHRA recognise the benefits of treatment with Agamree for bone health and growth,” Dr Shabir Hasham, Chief Medical Officer of Santhera Pharmaceuticals shared.

Medicine 105
article thumbnail

Santhera debuts DMD drug Agamree in Germany

pharmaphorum

Santhera’s new treatment for Duchenne muscular dystrophy Agamree has been launched in its first market, Germany, following its EU approval last month.

Marketing 105
article thumbnail

Could plastic alternative support environmentally-sustainable drug delivery?

European Pharmaceutical Review

The natural polymer tara gum polysaccharide ( Caesalpinia spinosa ) has application potential in pharmaceutical drug delivery , according to researchers in Korea. This is mainly due to its benefits such as its biocompatibility, biodegradability, and safety. A biodegradable alternative A study by the researchers, published in Carbohydrate Polymers , suggested that the material could be a natural, environmentally-friendly alternative to petroleum-based polymers such as plastic.

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Orion buys stake in LegoChem amid pivot to cancer and pain

pharmaphorum

Orion buys stake in LegoChem amid pivot to cancer and pain Phil.

105
105
article thumbnail

CellVoyant secures £7.6 million AI stem cell boost

PharmaTimes

CellVoyant’s platform combines AI with live cell imaging

98
article thumbnail

German union will resist any plan to split up Bayer

pharmaphorum

Germany’s IG BCE trade union has pushed back against any break-up of Bayer, claiming it could put thousands of domestic jobs at risk

105
105
article thumbnail

Kanabo and City Dock Pharmacy team up

PharmaTimes

Companies collaborate to launch walk-in pain clinic

95
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

MedCity FemFwd: Shortcomings in Menopause Care with Dr. Bruce Dorr

MedCity News

In this episode, we’re joined by Dr. Bruce Dorr, an OB-GYN. Dorr discusses how the lack of medical training for menopause has led to insufficient treatment.

article thumbnail

Basilea buys Spexis’ preclinical antibiotics programme for $2.3m

Pharmaceutical Technology

The acquired programme consists of antibiotics against gram-negative bacteria, including multidrug-resistant strains.

59
article thumbnail

Biosimilars Provide New Treatment Opportunities For Wide Range of Conditions

Pharmacy Times

Biosimilars are proven to be highly similar to the original products with no clinical meaningful differences.

58
article thumbnail

MSD’s Keytruda wins expanded FDA combo approval in cervical cancer

Pharmaceutical Technology

MSD’s blockbuster immunotherapy, set to lose patent protection in 2028, secures third FDA approval in cervical cancer.

FDA 59
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

Pharmacy Practice in Focus: Health Systems Launches the Peer-Review Process in 2024

Pharmacy Times

In 2024, Pharmacy Practice in Focus: Health Systems welcomes the launch of the peer-review process, with this issue containing our first peer-reviewed paper.

58
article thumbnail

Amgen showcases exciting potential in the obesity space at JPM24

Pharmaceutical Technology

If new treatments are shown to maintain weight loss, they will become game changers within the obesity space.

59
article thumbnail

Multilingual Pharmacists Create Bridge of Communication, Access for Patients

Pharmacy Times

Language barriers between pharmacists and patients impacts medication adherence, patient education, and overall health outcomes, resulting in patient harm.

article thumbnail

Artificial Intelligence in Pharmaceutical Manufacturing

PharmaTech

FDA is anticipating how AI may advance manufacturing and improve supply chain security.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Presentations at the ASH and SABCS Conferences Highlight Advancements in the Field of Oncology Pharmacy

Pharmacy Times

2023 was an impactful year for the field of oncology pharmacy.

57
article thumbnail

Moderating Innovation to Equipoise Risk

PharmaTech

As innovation accelerates, pharmaceutical regulators continue their path of maintaining proportion, balance, and restraint.

article thumbnail

Update: Orion buys stake in LegoChem as biotech push goes on

pharmaphorum

Update: Orion buys stake in LegoChem as biotech push goes on Phil.

52
article thumbnail

Appropriate Uses for Product Sterility Testing – When is Sterility Testing Appropriate?

PharmaTech

Webinar Date/Time: Wed, Mar 6, 2024 2:00 PM EST

52
article thumbnail

Signal-Based Selling: How to Leverage 4 Key Buying Signals

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

article thumbnail

Simulator-Driven SKO Prep: Boosting Readiness and Confidence

Quantified

Sales kickoff (SKO) events address many different objectives, such as energizing the sales team, communicating goals, and keeping everyone up to date on product releases. Education is one of the top seven objectives behind a well-run SKO event. Traditionally, this training would take the form of hands-on demos and in-person role-play scenarios. However, conventional sales role-play exercises have other challenges ranging from low engagement to the time demands they place on trainers.

Sales 52
article thumbnail

Best Practices, Strategies & Utilization of Novel Biological Responses for Robust Cell-Based Potency Assays

PharmaTech

Webinar Date/Time: Wed, Feb 28, 2024 11:00 AM EST

52
article thumbnail

FDA Clears AnX Robotica’s NaviCam SB for Expanded Indications

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52
article thumbnail

Precautionary Measures Recommended in Use of Valproate Medicines

PharmaTech

The European Medicines Agency safety committee says there is a potential risk of neurodevelopment disorders in children born to men treated with valproate.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven